Literature DB >> 27343361

O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.

Christina M Ferrer1, Valerie L Sodi1, Mauricio J Reginato2.   

Abstract

The hexosamine biosynthetic pathway (HBP) is highly dependent on multiple metabolic nutrients including glucose, glutamine, and acetyl-CoA. Increased flux through HBP leads to elevated post-translational addition of β-D-N-acetylglucosamine sugars to nuclear and cytoplasmic proteins. Increased total O-GlcNAcylation is emerging as a general characteristic of cancer cells, and recent studies suggest that O-GlcNAcylation is a central communicator of nutritional status to control key signaling and metabolic pathways that regulate multiple cancer cell phenotypes. This review summarizes our current understanding of changes of O-GlcNAc cycling enzymes in cancer, the role of O-GlcNAcylation in tumorigenesis, and the current challenges in targeting this pathway therapeutically.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  O-GlcNAcylation; OGT; cancer; glycosylation; signaling

Mesh:

Year:  2016        PMID: 27343361      PMCID: PMC4983259          DOI: 10.1016/j.jmb.2016.05.028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  95 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.

Authors:  Hyonchol Jang; Tae Wan Kim; Sungho Yoon; Soo-Youn Choi; Tae-Wook Kang; Seon-Young Kim; Yoo-Wook Kwon; Eun-Jung Cho; Hong-Duk Youn
Journal:  Cell Stem Cell       Date:  2012-05-17       Impact factor: 24.633

3.  Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition.

Authors:  Sang Yoon Park; Hyun Sil Kim; Nam Hee Kim; Suena Ji; So Young Cha; Jeong Gu Kang; Ichiro Ota; Keiji Shimada; Noboru Konishi; Hyung Wook Nam; Soon Won Hong; Won Ho Yang; Jürgen Roth; Jong In Yook; Jin Won Cho
Journal:  EMBO J       Date:  2010-10-19       Impact factor: 11.598

4.  Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.

Authors:  Thanong Phueaouan; Parunya Chaiyawat; Pukkavadee Netsirisawan; Daranee Chokchaichamnankit; Phaibul Punyarit; Chantragan Srisomsap; Jisnuson Svasti; Voraratt Champattanachai
Journal:  Oncol Rep       Date:  2013-10-11       Impact factor: 3.906

5.  Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).

Authors:  John W Bullen; Jeremy L Balsbaugh; Dipanjan Chanda; Jeffrey Shabanowitz; Donald F Hunt; Dietbert Neumann; Gerald W Hart
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

6.  GlcNAcylation plays an essential role in breast cancer metastasis.

Authors:  Yuchao Gu; Wenyi Mi; Yuqing Ge; Haiyan Liu; Qiong Fan; Cuifang Han; Jing Yang; Feng Han; Xinzhi Lu; Wengong Yu
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 7.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

Review 8.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

Review 9.  Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Authors:  W G Kaelin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-11-16

10.  O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.

Authors:  Xiongjian Rao; Xiaotao Duan; Weimin Mao; Xuexia Li; Zhonghua Li; Qian Li; Zhiguo Zheng; Haimiao Xu; Min Chen; Peng G Wang; Yingjie Wang; Binghui Shen; Wen Yi
Journal:  Nat Commun       Date:  2015-09-24       Impact factor: 14.919

View more
  94 in total

Review 1.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

Review 2.  Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.

Authors:  Christian Schneeweis; Matthias Wirth; Dieter Saur; Maximilian Reichert; Günter Schneider
Journal:  Small GTPases       Date:  2017-01-20

3.  Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode.

Authors:  Baobin Li; Hao Li; Lei Lu; Jiaoyang Jiang
Journal:  Nat Struct Mol Biol       Date:  2017-03-20       Impact factor: 15.369

Review 4.  Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.

Authors:  Chia-Wei Hu; Matthew Worth; Hao Li; Jiaoyang Jiang
Journal:  Chembiochem       Date:  2018-11-12       Impact factor: 3.164

Review 5.  "Nutrient-sensing" and self-renewal: O-GlcNAc in a new role.

Authors:  Nikita S Sharma; Ashok K Saluja; Sulagna Banerjee
Journal:  J Bioenerg Biomembr       Date:  2017-12-05       Impact factor: 2.945

Review 6.  Regulation of Carbohydrate Energy Metabolism in Drosophila melanogaster.

Authors:  Jaakko Mattila; Ville Hietakangas
Journal:  Genetics       Date:  2017-12       Impact factor: 4.562

Review 7.  Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Authors:  Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

8.  Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer.

Authors:  Kevin Qian; Simeng Wang; Minnie Fu; Jinfeng Zhou; Jay Prakash Singh; Min-Dian Li; Yunfan Yang; Kaisi Zhang; Jing Wu; Yongzhan Nie; Hai-Bin Ruan; Xiaoyong Yang
Journal:  J Biol Chem       Date:  2018-07-23       Impact factor: 5.157

9.  Metabolic Labeling for the Visualization and Identification of Potentially O-GlcNAc-Modified Proteins.

Authors:  Nichole J Pedowitz; Balyn W Zaro; Matthew R Pratt
Journal:  Curr Protoc Chem Biol       Date:  2020-06

10.  Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.

Authors:  Jin Xiang; Chang Chen; Rui Liu; Dongmei Gou; Lei Chang; Haijun Deng; Qingzhu Gao; Wanjun Zhang; Lin Tuo; Xuanming Pan; Li Liang; Jie Xia; Luyi Huang; Ke Yao; Bohong Wang; Zeping Hu; Ailong Huang; Kai Wang; Ni Tang
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.